Search filters

List of works by Holly Janes

A Framework for Evaluating Markers Used to Select Patient Treatment ⬇️

scientific article published on June 27, 2013

Accommodating Covariates in ROC Analysis

scientific article published on January 2009

Adjusting for Covariate Effects in Biomarker Studies Using the Subject-specfic Threshold Roc Curve ⬇️

doctoral thesis by Holly Janes, University of Washington, 2005

Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve

scientific article

Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial

scientific article

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

scientific article published on 01 November 2019

Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use.

scientific article published on 31 May 2016

Assessing the value of risk predictions by using risk stratification tables

scientific article

Assessing treatment-selection markers using a potential outcomes framework

scientific article

Case-crossover analyses of air pollution exposure data: referent selection strategies and their implications for bias

scientific article

Case-only approach to identifying markers predicting treatment effects on the relative risk scale ⬇️

scientific article published on 28 September 2017

Characterizing expected benefits of biomarkers in treatment selection

scientific article

Combining biomarkers to optimize patient treatment recommendations

scientific article

Commentary: Reporting standards are needed for evaluations of risk reclassification ⬇️

scientific article published on May 13, 2011

Cox models for ecologic time-series data?

scientific article published in December 2006

Designing a study to evaluate the benefit of a biomarker for selecting patient treatment

scientific article

Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?

scientific article published on 21 March 2016

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

scientific article published on 2 September 2015

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

scientific article published on 30 December 2020

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

scientific article

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

scientific article

Estimation and Comparison of Receiver Operating Characteristic Curves

scientific article published on March 2009

Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors

scientific article published on 19 September 2019

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial

scientific article

Fine particulate matter and mortality: a comparison of the six cities and American Cancer Society cohorts with a medicare cohort

scientific article published in March 2008

First things first: risk model performance metrics should reflect the clinical application

scientific article published in December 2017

HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders

scientific article

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

scientific article

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

scientific article published on March 2013

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

scientific article

Identifying post-menopausal women at elevated risk for epithelial ovarian cancer

scientific article

Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study)

scientific article

In Pursuit of an HIV Vaccine: Designing Efficacy Trials in the Context of Partially Effective Nonvaccine Prevention Modalities ⬇️

scientific article published on June 25, 2013

Insights into latent class analysis of diagnostic test performance

scientific article published on 3 November 2006

Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans

scientific article published on 30 January 2020

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

scientific article published on May 2004

MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load

scientific article

Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value

scientific article published on 14 May 2007

Measuring the Performance of Markers for Guiding Treatment Decisions ⬇️

scientific article published on February 15, 2011

Net reclassification indices for evaluating risk prediction instruments: a critical review

scientific article published on January 2014

Net risk reclassification p values: valid or misleading?

scientific article published on 28 March 2014

New clinical trial designs for HIV vaccine evaluation

scientific article published on September 2013

On quantifying the magnitude of confounding

scientific article

Overlap bias in the case-crossover design, with application to air pollution exposures

scientific article published in January 2005

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

scientific article published on 07 October 2008

Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials

scientific article published on 25 January 2017

Re: "Clinical Usefulness of the Framingham Cardiovascular Risk Profile beyond Its Statistical Performance: The Tehran Lipid and Glucose Study" ⬇️

scientific article published on March 22, 2013

Rejoinder: Combining biomarkers to optimize patient treatment recommendations

scientific article

Reply to A.J. Vickers et al.

scientific article

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial

scientific article published on 28 January 2016

Statistical analysis of air pollution panel studies: an illustration

scientific article published on October 2008

Statistical methods for down-selection of treatment regimens based on multiple endpoints, with application to HIV vaccine trials

scientific article published on 20 September 2016

Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration

scientific article published on 16 March 2011

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.

scientific article

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

scientific article (publication date: April 2011)

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment

scientific article

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies

scientific article

Trends in air pollution and mortality: an approach to the assessment of unmeasured confounding

scientific article published in July 2007

Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'.

scientific article

Use of placebos in Phase 1 preventive HIV vaccine clinical trials

scientific article

Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection

scientific article published on 21 July 2013

Paulina is supported by:

About Paulina

Help